CARLSBAD, Calif., Aug 04, 2010 (BUSINESS WIRE) --
LifeTechnologies Corporation (NASDAQ:LIFE) today announced the commercial availability of the Applied Biosystems AutoMate Express(TM) Forensic DNA Extraction System, which is designed to streamline sample preparation and improve downstream DNA profile quality. The system, designed and validated as part of the complete Applied Biosystems human identification workflow to provide optimal efficiency and data quality, has already been adopted by all 48 government forensic laboratories in Japan.
Forensic casework samples are often difficult and time consuming specimens to process, because they are often limited in quantity and may have been exposed to environmental factors. Inefficiencies in sample preparation can lead to sample loss, re-processing or complicated data interpretation, which can slow the process of obtaining conclusive results.
The AutoMate Express System is designed to establish a solid foundation for the entire human identification workflow by meeting the key requirements of a forensic DNA extraction method: flexibility of input sample type and delivery of high quantity and quality DNA for use in downstream STR analysis on an integrated genetic analysis platform, such as the Applied Biosystems 3500 Genetic Analyzer.
The new benchtop extraction system uses the innovative PrepFiler LySep(TM) Column to allow laboratories to perform lysis and substrate separation in a single step and minimize the handling of forensic evidence. In addition, the system uses PrepFiler(TM) chemistry to maximize efficient recovery of high quality DNA from challenging forensic sample types, including hair, teeth, and bone. For example, a hair or bone sample may require eight hours to several days to process with present methods, as compared to approximately 70 minutes to 2.5 hours using the AutoMate Express protocols.
"We're confident that DNA extracted on the AutoMate Express System will increase data quality for a wide range of forensic samples and facilitate improved downstream performance in the sample analysis workflow," said Leonard Klevan, Ph.D., President of the Human Identification business at Life Technologies. "Now forensic scientists across the globe can fully utilize this new system from Life Technologies to integrate the complete human identification workflow solution from sample preparation through analysis, enabling an unmatched level of performance, efficiency and data quality."
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
SOURCE: Life Technologies Corporation
Life Technologies
Lauren Lum, 650-638-6916
lauren.lum@lifetech.com
